inspra
viatris limited - eplerenone 50mg; eplerenone 50mg - film coated tablet - 50 mg - active: eplerenone 50mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow purified talc purified water sodium laurilsulfate active: eplerenone 50mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow purified talc purified water sodium laurilsulfate - inspra is indicated to reduce the risk of cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3 to 14 days of an acute myocardial infarction.
inspra 25 mg
pfizer pfe pharmaceuticals israel ltd - eplerenone - film coated tablets - eplerenone 25 mg - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < or = 40 % ) and clinical evidence of heart failure after recent myocardial infarction.inspra is indicated in addition to standard optimal therapy, to reduce the risk of cardiovascular morbidity and mortality in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef < or = 30%).
inspra 50 mg
pfizer pfe pharmaceuticals israel ltd - eplerenone - film coated tablets - eplerenone 50 mg - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < or = 40 % ) and clinical evidence of heart failure after recent myocardial infarction.inspra is indicated in addition to standard optimal therapy, to reduce the risk of cardiovascular morbidity and mortality in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef < or = 30%).
inspra 25 mg comprimidos recubiertos con pelicula
viatris healthcare limited - eplerenona - comprimido recubierto con pelÍcula - 25 mg - eplerenona 25 mg - eplerenona
inspra 50 mg comprimidos recubiertos con pelicula
viatris healthcare limited - eplerenona - comprimido recubierto con pelÍcula - 50 mg - eplerenona 50 mg - eplerenona
inspra
viatris healthcare d.o.o. - eplerenon -
inspra
viatris healthcare d.o.o. - eplerenon -
inspra 25 mg
fareva amboise - franta - eplerenonum - compr. film. - 25mg - diuretice care economisesc potasiul antagonisti ai aldosteronului (antialdosteronice)
inspra 50 mg
fareva amboise - franta - eplerenonum - compr. film. - 50mg - diuretice care economisesc potasiul antagonisti ai aldosteronului (antialdosteronice)
inspra 25 mg
fareva amboise - franta - eplerenonum - compr. film. - 25mg - diuretice care economisesc potasiul antagonisti ai aldosteronului (antialdosteronice)